baber/WOPTO huggingface dataset:
Patent NZ-517444-A (NZ)
Title: Collapsible stackable container with pins at lower corners to locate transversely on top of another collapsed container
Inventor: DOBSON MARK
IPC: B65D19/38
Filed: 1999-03-19
Abstract: A container (10) for transporting articles, including a base (20), a plurality of wall components (12, 14, 16, 18) coupled to the base (20) for defining a storage compartment, the wall components (12, 14, 16, 18) being collapsible so as to enable said container (10) to be placed in a collapsed condition, a base post (90) projecting upwardly at each corner of the container (10), the base post (90) projecting upwardly from the base and having a free end with an aperture (not shown) at its upper portion; a container foot (30) at each corner below each of the base posts (90), each foot (30) having a generally horizontal abutment surface (not shown), a downwardly projecting pin (not shown), and an angled abutment surface (98) extending downwardly at an angle from the vertical, and wherein a container (10) when in an erect article transporting condition is able to be stacked on another like container (10'), one above the other, by locating each foot (30) of the said container (10) upon the wall components of said like container (10') so that the generally horizontal abutment surface (not shown) is located on a part of the wall components (12, 14, 16, 18) and where the angled abutment surface (not shown) prevents the container (10) from sliding off the wall components (90), and when in a collapsed condition said container (10) can be stacked upon said like container (10') by locating the generally horizontal abutment surface (not shown) of each foot (30) on a corresponding base post (90) with the pin (not shown) of each foot (30) projecting into the aperture (104) of the base post (90) to thereby prevent the like container (10') from sliding off the said container (10).
Patent NZ-517775-A (NZ)
Title: Rapid sequencing of large DNA fragments by detecting enzyme conformational changes
Inventor: DENSHAM DANIEL HENRY
IPC: C12Q1/68
Filed: 2000-10-06
Abstract: A method for determining the sequence of a polynucleotide is described. The method relies on the detection of a conformational change in an enzyme that interacts with and processes along the polynucleotide. The detection of a conformational change may be carried out by measuring changes in a fluorophore bound to the enzyme. The target polypeptide does not comprise a fluorescent molecule. The graph illustrates a trace taken after fluorescence resonance energy transfer, wherein each of the peaks representing the detection of a specific nucleotide.
Patent NZ-526105-A (NZ)
Title: Aryl ether substituted imidazoquinolines as immunomodulators, for inducing cytokine biosynthesis
Inventor: CHARLES LESLIE JAYNE
IPC: A61P31/12
Filed: 2001-12-06
Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and aryl or alkenyl functionality at the 1-position and that are useful as immune response modifiers are disclosed. These compounds and compositions can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
Patent NZ-526746-A (NZ)
Title: Arsenious sulphide compounds other than As2O3 for treating hematological cancers such as leukemia or lymphoma
Inventor: LU DAOPEI
IPC: A61K33/36
Filed: 1998-07-06
Abstract: Arsenic sulphide compounds other than As2O3 are described. Also described are pharmaceutical compositions useful for treating cancer and methods for treating cancer, such as leukaemia or lymphoma, which comprise administration of an arsenic sulphide compound.
Patent NZ-527991-A (NZ)
Title: Carbamate compounds for use in preventing or treating psychotic disorders
Inventor: PLATA-SALAMAN CARLOS R
IPC: A61K31/27
Filed: 2002-02-21
Abstract: The use of a compound selected from the group consisting of Formula (I) and Formula (II), wherein the phenyl group is substituted at X with one to five halogen atoms; and R1, R2, R3, R4, R5, and R6 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the list consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano); for the preparation of a medicament for the prevention or treatment of psychotic disorders in a subject in need thereof is disclosed. The psychotic disorder may be selected from the list consisting of schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, brief psychotic disorder, shared psychotic disorder, psychotic disorder due to a general medical condition and substance-induced psychotic disorder.
Patent NZ-528197-A (NZ)
Title: Use of a tetracycline compound of treating acne
Inventor: ASHLEY ROBERT A
IPC: A61K31/65
Filed: 2002-04-05
Abstract: Use of a tetracycline compound, for example doxycycline, is disclosed to be for the preparation of a medicament for the treatment of acne in a human. The medicament is described to be formulated for administration without a bisphosphonate compound. The amount of tetracycline compound is to be effective to treat acne, but to have substantially no antibiotic activity.
Patent NZ-528935-A (NZ)
Title: Method of delaying ejaculation
Inventor: BAR-OR DAVID
IPC: A61K31/137
Filed: 2002-03-15
Abstract: A method of delaying ejaculation is disclosed, which comprises administering an effective amount of a tramadol material such as (±) cis-tramadol hydrochloride to a human male prior to sexual intercourse. The method is particularly useful for treating premature ejaculation. The term "tramadol material" used herein refers to 2-[(dimethylamino) methyl]-1-(3-methoxyphenyl)-cyclohexanol ("tramadol").
Patent NZ-530452-A (NZ)
Title: Augmentation of muscle contractility by biphasic stimulation
Inventor: MOWER MORTON M
IPC: A61N1/08
Filed: 1999-05-21
Abstract: Disclosed is an apparatus for stimulating muscle tissue with biphasic waveforms. The apparatus comprises pulse generation electronics that generate a pulse, the pulse defining a first stimulation phase and defining a second stimulation phase, wherein the first stimulation phase has a first phase polarity, a first phase amplitude, a first phase shape, and a first phase duration for preconditioning the muscle tissue to accept subsequent stimulation, and wherein the second stimulation phase has a polarity opposite to the first phase polarity, a second phase amplitude is larger in absolute value than the first phase amplitude, a second phase shape, and a second phase duration. The apparatus also comprises leads connected to the pulse generation electronics and being adapted to apply the first stimulation phase and the second stimulation phase in sequence to the muscle tissue, wherein the muscle tissue is selected from the group consisting of striated muscle, smooth muscle and mixed muscle, wherein the first phase amplitude is ramped from a baseline value to a second value. (62) Divided out of 509042
Patent NZ-535559-A (NZ)
Title: Pharmaceutical compounds useful in oxidative stress and/or endothelial dysfunction of moderate intensity
Inventor: DEL SOLDATO PIERO
IPC: C07C219/00
Filed: 2000-07-27
Abstract: Disclosed herein are compounds or their salts of general formula (I): A-B-N(O)s    -  ( I ) wherein:is 2; A = R-T1-, wherein T1 = CO; R is the drug radical as defined in the specification; B = -TB -X2-O-, wherein TB = O and X2 is a bivalent radical such that the precursor drug compound of B meets the pharmacological tests described in the specification. (62) Divided out of 516889
Patent NZ-541559-A (NZ)
Title: Socket wrench head with rotatable members retained in cage so as to transfer torque
Inventor: NIVEN DAVID
Filed: 2005-08-01
Abstract: A socket wrench head is disclosed with rotatable members, typically tapered rollers 13, retained by a cage 12 and a drive plate 14 such that the rotatable members 13 bear against and engage the flange face by way of torque being applied from an opposing face of the drive plate 14 as a wrench handle is rotated to rotate the drive plate and drive flange 10 together.
Patent NZ-542791-A (NZ)
Title: Compositions for mucosal and oral administration comprising HCG fragments
Inventor: KHAN NISAR ALUMED
IPC: A61P37/00
Filed: 2004-04-08
Abstract: Disclosed is the systemic treatment of inflammatory disease by oral or mucosal administration of a pharmaceutical composition with a gene-regulatory peptide. The invention provides a pharmaceutical composition in a form for mucosal application for the treatment of a subject suffering from disease, said pharmaceutical composition comprising a pharmacologically effective amount of a gene-regulatory peptide or a functional analogue thereof together with a pharmaceutically acceptable diluent.
Patent NZ-544139-A (NZ)
Title: Atmospheric pressure non-thermal plasma device to clean and sterilize the surface of probes, cannulas, pin tools, pippettes and spray heads
Inventor: KURUNCZI PETER FRANK
IPC: B08B3/10
Filed: 2004-05-28
Abstract: The invention relates to methods and apparatuses for the use of atmospheric pressure non-thermal plasma to clean and sterilize the surfaces of liquid handling devices. The end of a grounded fluid handling device (103) is inserted into the hollow open ended dielectric channel (101) to a point in between electrodes (102), connected to an AC power supply (104), and acts as the opposing electrode. In operation, a discrete plasma is formed in the interior of the channel to clean the fluid handling device.
Patent NZ-550754-A (NZ)
Title: Use of alkykl carboxylic acid amides for promoting the pentration of agrochemical active substances into plants
Inventor: ROCHLING ANDREAS
IPC: A01N43/653
Filed: 2005-04-22
Abstract: Disclosed is the use of one or more carboxamides of the formula (I): R1-CO-NR2R3 (I) in which R1 represents an unbranched, saturated alkyl group having 5 to II carbon atoms, R2 represents methyl and R3 represents methyl; for promoting the penetration of agrochemical active substances into plants, wherein said agrochemical active substances are selected from the group consisting of prothioconazole, N-(3',4'-dichloro-5-fluorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide and mixtures of prothioconazole with one or more active substances selected from spiroxamine, tebuconazole, fluoxastrobin and trifloxystrobin.
Patent NZ-551378-A (NZ)
Title: Enzymatic oil-degumming method
Inventor: SOE JORN BORCH
IPC: A23L29/00
Filed: 2005-07-18
Abstract: Disclosed is a process of enzymatic degumming edible oils, comprising treating the edible oil with a lipid acyltransferase so as to transfer an acyl group from a major part of the phospholipid to one or more acyl acceptors, wherein the acyl acceptor is one or more sterol and/or stanol and wherein the lipid acyltransferase: (a) possesses acyltransferase activity which is defined as ester transfer activity whereby the acyl part of an original ester bond of a lipid acyl donor is transferred to an acyl acceptor to form a new ester; and (b) comprises the amino acid sequence motif GDSX, wherein X is one or more of the following amino acid residues L, A, V, I, F, Y, H, Q, T, N, M or S, and wherein when aligned to either the pfam 00657 consensus sequence and/or SEQ ID No.37 the lipid acyltransferase has a GANDY block.
Patent NZ-552354-A (NZ)
Title: Methods and compounds for inhibiting amyloid deposits
Inventor: SZAREK WALTER A
IPC: A61K31/4152
Filed: 2000-05-24
Abstract: Disclosed are methods and compositions which are useful in the treatment of amyloidosis. In particular, methods and compositions containing compounds of the formula (I), are provided for inhibiting, preventing and treating amyloid deposition, e.g., in pancreatic islets, wherein the amyloidotic deposits are islet amyloid polypeptide (IAPP)-associated amyloid deposition or deposits. Accordingly the compositions and methods are useful for inhibiting IAPP-associated amyloidosis in disorders in which such amyloid deposition occurs, such as diabetes.
Patent NZ-555132-A (NZ)
Title: Sprayable aqueous fungicidal composition comprising soybean oil and anhydrous milk fat (AMF) for the treatment of Powdery Mildew
Inventor: CHEE ANNETTE AH
Filed: 2004-07-09
Abstract: A sprayable aqueous fungicidal composition consisting essentially of: (a) 0.1 to 1.5% v/v soybean oil, (b) one or more emulsifiers selected from polyglycerol esters of fatty acids, diacetyl tartaric acid esters of mono- and di-glycerides, sorbitan esters of fatty acids, mono- and di-glycerides, and a xanthan gum, or a mixture thereof, (c) one or more antioxidants, (d) optionally one or more of anhydrous milk fat (AMF), olive oil and coconut fat, or a mixture thereof, and (e) optionally one or more of a sulphur-based fungicide, a natural or organic fungicide, or an elicitor of plant defences, or a mixture thereof. The composition is used in prevention or control of infection caused by pathogens e.g. Powdery mildew (PM), and in the manufacture of an agent that inhibits germination of fungal spores.
Patent NZ-561570-A (NZ)
Title: Three-dimensional motion capture
Inventor: SULLIVAN STEVE
IPC: G03B17/00
Filed: 2006-03-16
Abstract: Disclosed is a motion capture apparatus comprising a support structure configured to be affixed to an object whose motion is to be tracked using one or more cameras. The support structure has a plurality of motion capture marks and is of sufficient rigidity that, in response to movement by the object, the marks on the support structure maintain substantially fixed distances from each other. Further disclosed is a motion capture system incorporating at least one of the apparatus and a computer system, where the motion capture marks on the apparatus are associated with a virtual skeleton. The orientation of the skeleton is then determined by receiving a frame from the cameras and aligning the motion capture marks with the virtual marks.
Patent NZ-562190-A (NZ)
Title: Systems, methods, and apparatus for highband burst suppression
Inventor: VOS KOEN BERNARD
IPC: G10L25/90
Filed: 2006-04-03
Abstract: A method of signal processing is disclosed. The method includes: calculating a first burst indication signal that indicates whether a burst is detected in a low-frequency portion of a speech signal; calculating a second burst indication signal that indicates whether a burst is detected in a high-frequency portion of the speech signal; generating an attenuation control signal according to a relation between the first and second burst indication signals; and applying the attenuation control signal to the high-frequency portion of the speech signal to generate a processed high-frequency signal.
Patent NZ-571901-A (NZ)
Title: Use of ramipril or ramiprilat for the prevention of congestive heart failure
Inventor: SCHOELKENS BERNWALD
IPC: A61K31/497
Filed: 2000-08-25
Abstract: Disclosed is the use of ramipril or ramiprilat or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the prevention or development of congestive heart failure (CHF) in a normotensive patient with no preexisting CHF where the patient is at high risk for a cardiovascular event due to a history of previous ischaemic heart disease, stroke, peripheral arterial disease or diabetes.
Patent NZ-580942-A (NZ)
Title: Method and apparatus for measuring ph of low alkalinity solutions
Inventor: XAIO CAIBIN
IPC: G01N21/27
Filed: 2008-04-15
Abstract: Disclosed is a method for measuring pH, comprising the steps of: - providing a pH sensor array having a plurality of pH indicator films, each said pH indicator film having a different indicator concentration; - applying said sensor array to a series of pH standard solutions having a known pH; - measuring a first pH response from each said pH indicator film simultaneously; - generating a calibration function representing said first pH response; - applying said sensor array to a low alkalinity sample solution having an unknown pH; - measuring a second pH response from each said pH indicator film simultaneously; - comparing said second pH response with said calibration function so as to obtain a preliminary pH value from each said pH indicator film; - generating a fitting function representing said preliminary pH values; and - extrapolating said fitting function when indicator concentration is zero to estimate the actual pH of said unknown sample. A system for measuring pH is also disclosed.
Patent NZ-584075-A (NZ)
Title: Device for winding successive strings of packaging
Inventor: VAN DEN BRINK RICHARD RUDOLF THEODOOR
IPC: B65H19/22
Filed: 2008-09-12
Abstract: Device (1) for winding successive strings, including a rotating winding shaft (12) provided with engagement means for strings of packaging, a removal mechanism (10) for removing a wound string from the winding shaft and a discharge path (25, 26). The rotating winding shaft is rotatably arranged on a carrier (5). The carrier and winding shaft are displaced from a position near a feed to a position near the discharge. The feed includes a feed path (3) which functions as a support for strings and which adjoins the winding shaft. The support includes a trough.
Patent NZ-584459-A (NZ)
Title: Cytomegalovirus vaccines and methods of production
Inventor: SHENK THOMAS
IPC: A61K39/245
Filed: 2008-10-10
Abstract: Disclosed is a method of making a cytomegalovirus (CMV) vaccine comprising: a) passaging a strain or an isolate of CMV in cultured cells of a first selected cell type, b) amplifying the strain or isolate of CMV in a second selected cell type, thereby producing a cell type-conditioned CMV, wherein the first and second cell types are different; and c) producing a CMV vaccine from the cell type-conditioned CMV.
Patent NZ-586123-A (NZ)
Title: Treatment of ovarian cancer with 4-iodo-3-nitrobenzamide in combination with topoisomerase inhibitors
Inventor: SHERMAN BARRY M
IPC: A61K31/505
Filed: 2008-11-12
Abstract: Disclosed is the use of 4-iodo-3-nitrobenzamide (pictured), or a metabolite or a pharmaceutically acceptable salt thereof, and at least one topoisomerase inhibitor for the treatment of metastatic ovarian cancer. Suitable topoisomerase inhibitors include topotecan, irinotecan, lurtotecan, exatecan and camptothecin.
Patent NZ-588851-A (NZ)
Title: Potent conjugates and hydrophilic linkers
Inventor: SINGH RAJEEVA
IPC: A61K39/00
Filed: 2009-04-30
Abstract: Disclosed is a compound of formula (1) or (1'): Z-Xl-(-CH2-CH2-O-)n-Yp-D (1) D-Yp-(-CH2-CH2-O-)n-Xl-Z (1') wherein: Z represents a reactive functionality that can form an amide or a thioether bond with a cell-binding agent wherein the reactive functionality is selected from the group consisting of a reactive carboxylic ester, a reactive sulfonic acid derivative, a reactive thioester group, a haloacetamide and a vinyl sulfone; D represents a maytansinoid; X represents an aliphatic, an aromatic or a heterocyclic unit attached to the cell-binding agent via a thioether bond, an amide bond, a carbamate bond, or an ether bond; Y represents an aliphatic, an aromatic or a heterocyclic unit attached to the drug via a covalent bond selected from the group consisting of a thioether bond, an amide bond, a carbamate bond, an ether bond, an amine bond, a carbon-carbon bond and a hydrazine bond; l is 0 or 1; p is 0 or 1; and n is an integer from 1 to 2000. Also disclosed is a cell-binding agent cytotoxic drug conjugate of formula (2) or (2'): CB-[Xl-(-CH2-CH2-O-)n-Yp-D]m (2) [D-Yp-(-CH2-CH2-O-)n-Xl]m-CB (2') CB represents a cell-binding agent, wherein the cell-binding agent is an antibody and m is an integer from 2 to 15. Other substituents are as disclosed above. Further disclosed is a composition comprising the conjugate and the use of the conjugate for the manufacture of a medicament for treating a disease selected from tumour, autoimmune diseases, graft rejections, graft versus host disease, viral infections, and parasite infections.
Patent NZ-590148-A (NZ)
Title: Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
Inventor: APODACA RICHARD
IPC: C07D295/20
Filed: 2005-12-29
Abstract: Disclosed are piperazinyl and piperidinyl urea compounds of formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described within the specification. An examples of a compound of formula (I) is 4-(3,4-dibromo-benzyl)-piperazine-1-carboxylic acid pyridine-4-ylamide. Further disclosed is a pharmaceutical composition comprising an effective amount of a compound of formula (I) and a pharmaceutically acceptable excipient, and the use of a compound of formula (I) in the preparation of a medicament for treating a disease, disorder, or medical condition mediated by FAAH activity.
Patent NZ-590484-A (NZ)
Title: A system and method for controlling multiple sized water softening tanks
Inventor: QUINN KERRY
IPC: C02F1/42
Filed: 2011-01-13
Abstract: A water softening system including a first treatment tank having a first water capacity, a second treatment lank in parallel with the first treatment tank and having a second water capacity that is less than the first water capacity, a flow meter connected to the first and second treatment tanks, the flow meter configured to determine a demand flow rate of water entering the system and a controller in communication with the flow meter, the controller configured to direct the water into the first treatment tank when the demand flow rate is greater than a designated flow rate, and to direct the water into the second treatment tank when the demand flow rate is equal to or less than the designated flow rate.
Patent NZ-591213-A (NZ)
Title: A formulation of canfosfamide consisting of 50 mg/mL canfosfamide hydrochloride in aqueous sodium citrate buffer
Inventor: HUGHES BETSY R
IPC: A61K31/664
Filed: 2009-08-04
Abstract: Disclosed is a formulation of canfosfamide consisting essentially of (50±5) mg/mL canfosfamide hydrochloride in (100±10) mM aqueous sodium citrate buffer at pH 4.6±0.2. Also disclosed is a formulation consisting essentially of 50 mg/ mL canfosfamide hydrochloride, 100 mM sodium citrate dihydrate, and 2.9 mM citric acid monohydrate in water at pH 4.6±0.2.
Patent NZ-593021-A (NZ)
Title: Method of preparing deoxyribofuranose compounds
Inventor: HALEY GREGORY J
IPC: A01N43/90
Filed: 2009-11-16
Abstract: Disclosed is a method for making deoxyribofuranose compounds of formula (2) which are useful intermediates in the preparation of pharmaceutical compounds such as 5-amino-3-(2'-O-acetyl-3'-deoxy-B-D-ribofuranosyl)-3H-thiazolo[4,5-d]pyrimidin-2-one.
Patent NZ-593794-A (NZ)
Title: Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
Inventor: PORCELLI STEVEN A
IPC: A61K39/00
Filed: 2010-01-08
Abstract: Patent No. 593794 Disclosed is a modified bacterium comprising: a bacterial cell and a heterologous ceramide-like glycolipid, wherein said ceramide-like glycolipid is physically associated with said bacterial cell, and wherein said ceramide-like glycolipid stimulates natural killer T (NKT) cells.
Patent NZ-599306-A (NZ)
Title: Process for the preparation of compounds useful as inhibitors of sglt2
Inventor: FARINA VITTORIO
IPC: C07D409/10
Filed: 2010-10-14
Abstract: Disclosed herein is a process for the preparation of compounds of formula (I): or a pharmaceutically acceptable salt or solvate thereof; comprising: formula (VII) (VIII) (IX) reacting a compound of formula (VII), wherein M2 is a zinc species, with a compound of formula (VIII), wherein each Z is an independently selected oxygen protecting group and wherein LG2 is a leaving group; in a mixture of an ether solvent and a hydrocarbon solvent; to yield the corresponding compound of formula (IX); de-protecting the compound of formula (IX); to yield the corresponding compound of formula (I).